ALNAJASHI, Hind. Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment. Journal of Contemporary Medical Sciences, [S. l.], v. 11, n. 4, 2025. DOI: 10.22317/jcms.v11i4.1916. Disponível em: https://jocms.org/index.php/jcms/article/view/1916. Acesso em: 23 oct. 2026.